Mast cell leukaemia progressed from myelodysplastic syndrome after acquiring KIT mutation.

Autor: Xu K; Department of Haematology, University College London Hospitals NHS Foundation Trust, University College London, London, UK.; Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories, University College London Hospitals NHS Foundation Trust, University College London, London, UK., Childerhouse A; Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories, University College London Hospitals NHS Foundation Trust, University College London, London, UK.; Department of Histopathology, University College London Hospitals NHS Foundation Trust, University College London, London, UK., Gupta R; Department of Haematology, University College London Hospitals NHS Foundation Trust, University College London, London, UK.; Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories, University College London Hospitals NHS Foundation Trust, University College London, London, UK.
Jazyk: angličtina
Zdroj: International journal of laboratory hematology [Int J Lab Hematol] 2024 Apr; Vol. 46 (2), pp. 212-213. Date of Electronic Publication: 2023 Sep 18.
DOI: 10.1111/ijlh.14174
Databáze: MEDLINE
Externí odkaz: